Literature DB >> 10089152

Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.

X Zhang1, S M Kelly, W Bollen, R Curtiss.   

Abstract

We previously reported that Salmonella typhimurium SR-11 mutants with deletion mutations in the genes encoding adenylate cyclase (cya) and the cAMP receptor protein (crp) are avirulent and protective in mice. Salmonella typhimurium UK-1 is highly virulent for chicks (oral LD50 of 3x10(3) CFU) and mice (oral LD50 of 8.5x10(3) CFU) and is capable of lethal infections in pigs, calves and horses. We postulated that attenuated derivatives of this lethal strain would probably induce a higher level of protective immunity than achieved with attenuated derivatives of less virulent S. typhimurium strains such as SR11. To test this hypothesis, we have constructed S. typhimurium UK-1 Deltacya-12Deltacrp-11 mutant strain chi3985 and its virulence plasmid cured derivative chi4095 to investigate their avirulence and immunogenicity in mice. We found that the mutants are avirulent and able to induce protective immune responses in BALB/c mice. These mutant strains retained wild-type ability to colonize the gut associated lymphoid tissue but reach and persist in spleen and liver at a significantly lower level than the wild-type parent strain. Mice survived oral infection with >1x10(9) CFU of chi3985 (the equivalent to 10(5) 50% lethal doses of wild-type S. typhimurium UK-1) and were fully protected against challenge with 10(5)times the LD50 of the wild-type parent. Immunized mice developed a high level of serum IgG titre to Salmonella LPS and delayed-type hypersensitivity (DTH) response to S. typhimurium outer membrane proteins. Compared to the virulence plasmid-containing strain chi3985, the virulence plasmid cured DeltacyaDeltacrp mutant strain chi4095 was more attenuated and less protective, as some mice immunized with chi4095 died when challenged with the wild-type UK-1 strain. This work demonstrates that S. typhimurium UK-1 Deltacrp Deltacya mutant strain may be a potential live vaccine to induce protective immunity against Salmonella infection or to deliver foreign antigens to the immune system. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089152     DOI: 10.1006/mpat.1998.0245

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

1.  Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

Authors:  Sharon M Tennant; Jin-Yuan Wang; James E Galen; Raphael Simon; Marcela F Pasetti; Orit Gat; Myron M Levine
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

2.  Complete genome sequence of the universal killer Salmonella enterica Serovar Typhimurium UK-1 (ATCC 68169).

Authors:  Yingqin Luo; Qingke Kong; Jiseon Yang; Greg Golden; Soo-Young Wanda; Roderick V Jensen; Peter B Ernst; Roy Curtiss
Journal:  J Bacteriol       Date:  2011-05-27       Impact factor: 3.490

3.  Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium.

Authors:  S J McSorley; M K Jenkins
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.

Authors:  H Chen; D M Schifferli
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Lipopolysaccharide-specific but not anti-flagellar immunoglobulin A monoclonal antibodies prevent Salmonella enterica serotype enteritidis invasion and replication within HEp-2 cell monolayers.

Authors:  Ianko D Iankov; Dragomir P Petrov; Ivan V Mladenov; Iana H Haralambieva; Ivan G Mitov
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  A naturally occurring single nucleotide polymorphism in the Salmonella SPI-2 type III effector srfH/sseI controls early extraintestinal dissemination.

Authors:  Joshua M Thornbrough; Micah J Worley
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Comparative genome analysis of the high pathogenicity Salmonella Typhimurium strain UK-1.

Authors:  Yingqin Luo; Qingke Kong; Jiseon Yang; Arindam Mitra; Greg Golden; Soo-Young Wanda; Kenneth L Roland; Roderick V Jensen; Peter B Ernst; Roy Curtiss
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

8.  The Salmonella Pathogenicity Island (SPI) 1 contributes more than SPI2 to the colonization of the chicken by Salmonella enterica serovar Typhimurium.

Authors:  Yakhya Dieye; Keith Ameiss; Melha Mellata; Roy Curtiss
Journal:  BMC Microbiol       Date:  2009-01-06       Impact factor: 3.605

9.  Effects of crp deletion in Salmonella enterica serotype Gallinarum.

Authors:  Valentina Rosu; Mark S Chadfield; Antonella Santona; Jens P Christensen; Line E Thomsen; Salvatore Rubino; John E Olsen
Journal:  Acta Vet Scand       Date:  2007-05-08       Impact factor: 1.695

10.  Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid.

Authors:  Clare L Kinnear; Richard A Strugnell
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.